Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
for
Autoimmune Lymphoproliferative Syndrome
Location: Philadelphia PA, Bethesda MD, Houston TX
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 16 - 70+
Code: NCT06730126
Phase 2, Recruiting
US National OCS Liver Perfusion (OLP) Registry
for
Liver Transplant
Location: Boston MA, Burlington MA, New York NY, Philadelphia PA,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT05940857
Recruiting
Brief Behavioral Sleep Intervention for Obesity Prevention in Primary Care
for
Obesity, Childhood, Short Sleep, Obesity Prevention
Location: Philadelphia PA
Sponsor: Temple University
Sex: All
Age: 6 - 11
Code: NCT06810557
Recruiting
Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
for
Hiv
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT06263426
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of the PACE/PACENET BHL Clinical Program
for
Depression, Anxiety, Pain, Chronic
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 65+
Code: NCT02463266
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Sponsor: Clinical Evaluation Research Unit at Kingston General Hospital
Sex: All
Age: 55+
Code: NCT02920086
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
for
Asthma
Location: Worcester MA, Maspeth NY, Toms River NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06932263
Phase 2, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Boston MA, The Bronx NY, New York NY, Burlington VT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase 1, Recruiting
Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC
for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC),
Location: Pittsburgh PA
Sponsor: Dan Zandberg
Sex: All
Age: 18+
Code: NCT06052839
Phase 2, Recruiting
AWARE: Management of ADHD in Autism Spectrum Disorder
for
ADHD, Autism Spectrum Disorder
Location: Portland ME, Boston MA, Philadelphia PA,
Sponsor: Daniel Coury
Sex: All
Age: 4 - 17
Code: NCT05916339
Phase 4, Recruiting
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
for
Duchenne Muscular Dystrophy
Location: Philadelphia PA, Norfolk VA, Toronto, Columbus OH,